C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2002
10/17/2002	WO2002062301A3 Method and composition for rejuvinating cells, tissues, organs, hair and nails
10/17/2002	WO2002044156A3 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
10/17/2002	WO2002019213A3 Method for treatment of migraine using pde5 inhibitors
10/17/2002	WO2002006287A3 Macrocyclic mri contrast agents
10/17/2002	WO2001058241A9 Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver
10/17/2002	US20020151713 Substituted 6,5-hetero-bicyclic derivatives
10/17/2002	US20020151558 Triazolo compounds as MMP inhibitors
10/17/2002	US20020151556 Method and associated compounds for forming nanotubes
10/17/2002	US20020151549 Such as 3-(6-bromo-2-methylimidazo(1,2-a)pyridin-3-yl)-1H-pyrazol-1-yl 2-methyl-5-nitrophenyl sulfone; useful as phosphatidylinositol-3-kinase (PI3K) inhibitors and antitumor agents
10/17/2002	DE10118306A1 Composition for intranasal administration of imidazo-triazinone derivative cGMP PDE inhibitor for treatment of erectile dysfunction, also containing local anesthetic to prevent nasal blockage and improve absorption
10/17/2002	DE10115893A1 Preparation of sulfonamide derivatives of metallic phthalocyanines, useful for the sweetening of light petroleum distillates and LPG, comprises treatment with chlorosulfonic acid and an agent such as thionyl chloride, followed by amination
10/17/2002	CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	CA2442904A1 Benzamidine derivative
10/17/2002	CA2442695A1 Indolinones substituted in the 6-position, the preparation thereof and their use as medicaments
10/17/2002	CA2440724A1 Pyrazolopyrimidines as therapeutic agents
10/17/2002	CA2440196A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
10/16/2002	EP1249452A1 Fungicidal 5-Alkylamino-6-phenyl-7-halo-triazolopyrimidines
10/16/2002	EP1248824A2 Novel colorants, colorant stabilizers, ink compositions, and improved methods of making the same
10/16/2002	EP1248790A1 Proton pump inhibitors
10/16/2002	EP1248787A2 Novel subtituted pyrazolo[4, 3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them
10/16/2002	EP1248784A1 Condensed azepines as vasopressin agonists
10/16/2002	EP1248651A1 Product comprising a heterotrimeric g protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension
10/16/2002	EP1248623A2 Treatment of diabetic ulcers
10/16/2002	EP0998466B1 A process for the preparation of tetraazamacrocycles
10/16/2002	EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002	EP0538297B9 Antiviral tetrahydroimidazo 1,4]benzodiazepin-2-(thio)ones
10/16/2002	CN1374962A 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives
10/16/2002	CN1374961A Azepinoindole derivatives, the production and use thereof
10/16/2002	CN1374953A Aromatic nitrogenous six-membered ring compounds
10/16/2002	CN1374866A Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/16/2002	CN1092660C Process for preparing cedinafei
10/16/2002	CN1092659C Novel pyrimidine derivative
10/15/2002	US6465660 Isoindoloindolone compounds
10/15/2002	US6465657 Method of preparing refined organic compound for use in photography with improved liquid-liquid extraction from organic reaction mixture
10/15/2002	US6465651 Process and intermediates for growth hormone secretagogues
10/15/2002	US6465648 Obtainable by reacting (i) a nitrile derivative, (ii) a phthalonitrile derivative or a 1,3-diiminoisoindoline derivative and, if necessary, (iii) a metal or a metal-containing compound, such as titanium.
10/15/2002	US6465511 Treatment of septic shock
10/15/2002	US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002	US6465485 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/15/2002	US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002	US6465462 Cognition enhancement for dementing illnesses such as alzheimer's disease
10/15/2002	US6465259 Non radioactive receptor assay suitable for quantitative and qualitative analysis of trace amounts of receptor binding analyte
10/10/2002	WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002	WO2002079205A1 A process for synthesis of a prophyrin compound using a molecular sieve catalyst under microwave irridation
10/10/2002	WO2002079204A1 8-thiazolyl[1,2,4]triazolo[1,5-c]pyrimidine derivative
10/10/2002	WO2002079203A1 Imidazo-triazine derivatives as pde 5 inhibitors
10/10/2002	WO2002079202A1 Method for the production of 4,6-diaminopyrimido[5,4-d]pyrimidines
10/10/2002	WO2002079189A2 Spiroisoquinoline compounds, methods for their preparation and intermediates
10/10/2002	WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	WO2002078695A1 Thiaporphyrin, selenaporphyrin, and carotenoid porphyrin compounds as c-myc and telomerase inhibitors
10/10/2002	WO2002078694A1 Photosensitiser and method for production thereof
10/10/2002	WO2002078689A1 Bone metabolism improving agents
10/10/2002	WO2002078680A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002	WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002060422A3 Treatment of diabetes mellitus using vardenafil
10/10/2002	WO2002060386A3 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
10/10/2002	WO2002057287A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/10/2002	WO2002051845A3 Triazolopyrimidines
10/10/2002	WO2001078780A1 Preventives/remedies for alzheimer's disease
10/10/2002	US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002	US20020147338 Pyrazolotriazines as CRF antagonists
10/10/2002	US20020147194 Psychological disorders; antiserotonin agents; headache therapy
10/10/2002	US20020147160 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/10/2002	DE10117204A1 In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinones, their preparation and their use as medicaments
10/10/2002	DE10116399A1 Substituierte Azolazin(thi)one Substituted Azolazin (thi) ones
10/10/2002	DE10116303A1 Preparation of N-bridged heterobicyclic compounds, e.g. imidazolpyridine or triazolophthalazine compound, comprises oxidizing aldimine or hydrazone derivatives of N-heterocyclic compounds with copper(II) ions
10/10/2002	CA2442692A1 Bone metabolism improving agents
10/10/2002	CA2442329A1 Imidazo-triazine derivatives as pde 5 inhibitors
10/10/2002	CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	CA2439842A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002	CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	CA2406832A1 Preventives/remedies for alzheimer's disease
10/09/2002	EP1247804A1 Pyrimidine-thioalkyl and alkylether compounds
10/09/2002	EP1247655A1 Optical recording medium and novel azaporphyrin compounds
10/09/2002	EP1246829A1 Novel heterocycles
10/09/2002	EP1246826A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
10/09/2002	EP1246825A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
10/09/2002	EP1246824A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
10/09/2002	EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002	EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002	EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
10/09/2002	EP1141142B1 Improved method for producing thermally cleavable, soluble pigment derivatives
10/09/2002	EP1108000B1 Process for the preparation of substituted amido phthalocyanine derivatives and substituted amido phthalocyanine derivatives
10/09/2002	CN1092195C N-([1,2,4]triazoloazinyl]-benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides
10/08/2002	US6462192 Such as meso-formyl porphyrins, meso-acrylate porphyrins, purpurins and benzochlorins. in particular, tin ethyl etiopurpurin (snet2) and the intermediates necessary for its production without chromatography
10/08/2002	US6462044 Therapy for sexual disorders
10/06/2002	WO2003088897A2 Fab i inhibitors
10/06/2002	CA2444597A1 Fab i inhibitors
10/03/2002	WO2002076988A2 Tert. alkylphenoxy substituted polycyclic compounds
10/03/2002	WO2002076987A1 (oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides
10/03/2002	WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002	WO2002076983A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002	WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002	WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002	WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002	WO2002076459A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/03/2002	WO2002076453A1 Methods and compositions for photo-cross linking photoactive compounds to target tissue
10/03/2002	WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002	WO2002076375A2 Process for the preparation of benazepril

1 ... 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 ... 573